Cell division patterns in acute myeloid leukemia stem-like cells determine clinical course: A model to predict patient survival

Cancer Research

Volumn 75, Issue 6, 2015, Pages 940-949

  Stiehl, Thomas ^a   Baran, Natalia ^a   Ho, Anthony D ^a   Marciniak Czochra, Anna ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER PROGNOSIS; CANCER STEM CELL; CANCER SURVIVAL; CELL DIVISION; CELL PROLIFERATION; CELL RENEWAL; CLINICAL ARTICLE; HUMAN; HUMAN CELL; LEUKEMIA RELAPSE; LEUKEMIA STEM LIKE CELL; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; COMPUTER SIMULATION; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RECURRENT DISEASE; THEORETICAL MODEL;

CELL DIVISION; COMPUTER SIMULATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MODELS, THEORETICAL; NEOPLASTIC STEM CELLS; PROGNOSIS; RECURRENCE;

EID: 84937512406     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-2508     Document Type: Article

References (50)

1. Shinjo K, Takeshita A, Ohnishi K, Ohno R. Granulocyte colony-stimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells. Leuk Lymphoma 1997;25:37-46.
2. Cogle CR, Goldman DC, Madlambayan GJ, Leon RP, Al Masri A, Clark HA, et al. Functional integration of acute myeloid leukemia into the vascular niche. Leukemia 2014;28:1978-87.
3. Krause DS, Fulzele K, Catic A, Sun CC, Dombkowski D, Hurley MP, et al. Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat Med 2013;19:1513-7.
4. Layton JE, Hockman H, Sheridan WP, Morstyn G. Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood 1989;74:1303-7.
5. + cell dose on engraftment after stem cell transplantations: personalized estimates based on mathematical modeling. Bone Marrow Transplant 2014;49:30-37.
6. Marciniak-Czochra A, Stiehl T, Jager W, Ho AD, Wagner W. Modeling of asymmetric cell division in hematopoietic stem cells - regulation of self-renewal is essential for efficient repopulation. Stem Cells Dev 2009;18:377-85.
7. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-7.
8. Lutz C, Hoang VT, Ho AD. Identifying leukemia stem cells - is it feasible and does it matter? Cancer Lett 2013;338:10-14.
9. Chen SY, Huang YC, Liu SP, Tsai FJ, Shyu WC, Lin SZ. An overview of concepts. Cell Transplant 2011;20:113-120.
10. Buss EC, Ho AD. Leukemia stem cells. Int. J. Cancer 2011;129:2328-36.
11. Kihara R, Nagata Y, Kiyoi H, Kato T, Yamamoto E, Suzuki K, et al. Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients. Leukemia 2014.
12. EH Estey. Acute myeloid leukemia: 2013 update on risk-stratification and management. Am J Hematol 2013;88:318-27.
13. Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004;5:738-743.
14. Wright NA. Stem cell identification - in vivo lineage analysis versus in vitro isolation and clonal expansion. J Pathol 2012;227:255-266.
15. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012;481:506-510.
16. Gutierrez SE, Romero-Oliva FA. Epigenetic changes: a common theme in acute myelogenous leukemogenesis. J Hematol Oncol 2013;6:57.
17. Gentles AJ, Plevritis SK, Majeti R, Alizadeh AA. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 2010;304:2706-15.
18. Marcucci G, Maharry KS, Metzeler KH, Volinia S, Wu YZ, Mrozek K, et al. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol 2013;31:2068-93.
19. Gudgin EJ, Huntly BJP. Acute myeloid leukemia: leukemia stem cells write a prognostic signature. Stem Cell Res Ther 2011;2:1-3.
20. Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 2014;506:328-33.
21. Gale RE, Green C, Allen C, Mead AJ, Burnett AK, Hills RK, et al. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood 2008;111:2776-84.
22. Bacher U, Haferlach C, Kern W, Haferlach T, Schnittger S. Prognostic relevance of FLT3-TKD mutations in AML: the combination matter - an analysis of 3082 patients. Blood 2008;111:2527-37.
23. Renneville A, Roumier C, Biggio V, Nibourel O, Boissel N, Fenaux P, et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia 2008;22:915-31.
24. Schaub FX, Looser R, Li S, Hao-Shen H, Lehmann T, Tichelli A, et al. Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood 2010;115:2003-7.
25. Jan M, Majeti R. Clonal evolution of acute leukemia genomes. Oncogene 2013;32:135-140.
26. Jan M, Snyder TM, Corces-Zimmerman MR, Vyas P, Weissman IL, Quake SR, et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med 2012;4:149ra118.
27. Stiehl T, Marciniak-Czochra A. Mathematical modelling of leukemogenesis and cancer stem cell dynamics. Math Mod Nat Phenom 2012;7:166-202.
28. Roeder I. Quantitative stem-cell biology: computational studies in the hematopoietic system. Curr Opinion Hematol 2006;13:222-8.
29. Foley C, Mackey MC. Dynamic hematological disease: a review. J Math Biol 2009;58:285-322.
30. Whichard ZL, Sarkar CA, Kimmel M, Corey SJ. Hematopoiesis and its disorders: a systems biology approach. Blood 2010;115:2339-47.
31. Liso A, Castiglione F, Cappuccio A, Stracci F, Schlenk RF, Amadori S, et al. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1). Haematologica 2008;93:1219-26.
32. Scholz M, Engel C, Loeffler M. Modelling human granulopoiesis under poly-chemotherapy with G-CSF support. J Math Biol 2005;50:397-439.
33. Wodarz D, Garg N, Komarova NL, Ohad B, Keating MJ, Wierda WG, et al. Kinetics of chronic lymphocytic leukemia (CLL) cells in tissues and blood during therapy with the BTK inhibitor ibrutinib. Blood 2014.
34. Stiehl T, Marciniak-Czochra A. Characterization of stem cells using mathematical models of multistage cell lineages. Math Comp Model 2011;53:1505-17.
35. Marciniak-Czochra A, Stiehl T Mathematical models of hematopoietic reconstitution after stem cell transplantation. In:Bock HG, Carraro T, Jaeger W, Koerkel S eds. Model based parameter estimation: theory and applications. Heidelberg, Germany: Springer; 2011.
36. Jandl JH Blood cell formation. In:Jandl JH ed. Textbook of hematology. Boston, MA: Little, Brown and Company; 1996. p. 1-69.
37. Lansdorp PM. Stem cell biology for the transfusionist. Vox Sang 1998;74(Suppl 2):91-94.
38. Walenda T, Stiehl T, Braun H, Fröbel J, Ho AD, Schroeder T, et al. Feedback signals in myelodysplastic syndromes: increased self-renewal of the malignant clone suppresses normal hematopoiesis. PLoS Comp Biol 2014;10:e1003599.
39. Metcalf D. Hematopoietic cytokines. Blood 2008;111:485-491.
40. Lander A, Gokoffski K, Wan F, Nie Q, Calof A. Cell lineages and the logic of proliferative control. PLoS Biol 2009;7:84-100.
41. Stiehl T, Baran N, Ho AD, Marciniak-Czochra A. Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse. J R Soc Interface 2014;11:20140079.
42. Savitskiy VP, Shman TV, Potapnev MP. Comparative measurement of spontaneous apoptosis in pediatric acute leukemia by different techniques. Cytom B Clin Cytom 2003;56:16-22.
43. Armitage P, Berry G, Matthews JNS eds. Statistical methods in medical research, 4th ed. Oxford, United Kingdom: Blackwell Science Ltd.; 2002.
44. Everitt B, Hothorn T eds. A handbook of statistical analyses using R, 2nd ed. London, United Kingdom: Chapman and Hall CRC; 2010.
45. Lutz C, Woll PS, Hall G, Castor A, Dreau H, Cazzaniga G, et al. Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia. Leukemia 2013;27:1204-7.
46. Astori G, Malangone W, Adami V, Risso A, Dorotea L, Falasca E. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use. Blood Cells Mol Dis 2001;27:715-24.
47. Roodman GD, LeMaistre CF, Clark GM, Page CP, Newcomb TF, Knight WA. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy. Bone Marrow Transplant 1987;2:165-73.
48. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Nature 2011;294:1933-6.
49. Schroeder MA, DiPersio JF. Mobilization of hematopoietic stem and leukemia cells. J Leukoc Biol 2012;91:47-57.
50. Morton CI, Hlatky L, Hahnfeldt P, Enderling H. Non-stem cancer cell kinetics modulate solid tumor progression. Theor Biol Med Model 2011;8:48.